Share 0
Share 0
Post 0

Oral GLP-1s without fasting or reduced efficacy: Delivery approach protects peptide-based drugs from stomach acid

Wednesday, May 20th, 2026

Biomedical engineers at Duke University have developed a new approach to delivering GLP-1 medications orally that does not require fasting and maintains their efficacy. The technique could also be useful for any pharmaceutical based on peptides such as insulin or treatments for irritable bowel syndrome, HIV and osteoporosis.

WE WANT YOU!

are you a developer?

  • Proven International Track Record
  • Vertically Integrated Federal Funds
  • Vertically Integrated Tax Credits
  • Vertically Integrated Investors
  • Vertically Integrated Lenders
  • Vertically Integrated Contractors
 List your project

Report

Contains abusive or threatening content.
There has been a breach of confidentiality.
There has been a breach of contract.
There has been a breach of fiduciary within a partnership.
Contains mature, sensitive, or otherwise inappropriate content.
Contains misleading or false information with perceived intent.
Harassment or otherwise unwanted, unprofessional, or excessive communication or attempted communication.
Contains spam, potential malware, or otherwise not generally professional content.

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .